Clinical trial · Interventional
Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia
Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia
NCT05872464CI-TRIAL-00078181unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objectives of this study are to evaluate efficacy and safety of artificial saliva containing cumin and ginger extract in head and neck cancer patients with xerostomia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Xerostomia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Artificial saliva containing cumin and ginger extract | Other | — | UNRESOLVED |
| Placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Artificial saliva containing cumin and ginger extract
- description
- Artificial saliva containing cumin and ginger extract in spray bottle
- interventionNames
- Other: Artificial saliva containing cumin and ginger extract
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Placebo containing composition close to the test group without cumin and ginger extract in spray bottle
- interventionNames
- Other: Placebo
Primary outcomes (1)
- measure
- Amount of saliva
- timeFrame
- 14 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age more than 18 years * Head and neck cancer with xerostomia * 6 months post radiation * Willing to participate in this study Exclusion Criteria: * Sialolith or Sjogren's syndrome * Uncontrolled cancer * Using artificial saliva more than 2 weeks * Taking Pilocarpine or cevimeline more than 2 weeks * Allergic to cumin, ginger, xylitol, and glycerin * History of other oral mucosal diseases * Pregnancy and lactation
References
Publications (0)
Data not yet available
No reference posted for this study.